Last reviewed · How we verify

NCT05912868: EMILOS

Endoscopic Mini/Less Open Sublay(EMILOS) Repair

Completed Last updated 22 June 2023
What this trial tests

trial testing Endoscopic Mini/Less Open Sublay Repair in Hernia, Ventral in 174 participants. Completed in 31 December 2022.

Timeline
25 June 2015
Primary endpoint
27 January 2021
31 December 2022

Quick facts

Lead sponsorDiakonie-Klinikum Stuttgart
StatusCompleted
Study typeOBSERVATIONAL
Enrollment174
Start date25 June 2015
Primary completion27 January 2021
Estimated completion31 December 2022
Sites3 locations across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Diakonie-Klinikum Stuttgart

Who can join

18 and older, any sex, with Hernia, Ventral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ventral hernias in the midline of the abdominal wall are one of the most frequent diseases in general and visceral surgery worldwide. The optimal operative technique is still in discussion. The traditional techniques are open sublay or transabdominal intraperitoneal onlay mesh (IPOM) repair. In order to avoid the risks -large trauma to the abdominal wall with pain and infection, lesion of intraabdominal organs - a new hybrid technique - small skin incision, wide endoscopic dissection of the retrorectus space with implantation of a large mesh - was developed (EMILOS -Endoscopic Mini/Less Open Sublay).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hernia, Ventral

Currently open trials in the same condition.

Other Diakonie-Klinikum Stuttgart trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05912868.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing